Health
Regenxbio Gene Therapy Trial Paused Again
The FDA has once again paused a Regenxbio gene therapy trial due to new safety concerns. This follows previous holds on the same trial.
Coverage timeline — 1 article
STAT News
The FDA put a hold on a Regenxbio gene therapy trial again after new safety concerns emerged.
2026-08-24 11:59 UTC